Instituto Mexicano del Seguro Social, Guanajuato
Gln223arg polymorphism in leptin receptor gene linked to obesity traits
Published in Pharma Law Weekly, September 27th, 2005
"Polymorphisms of leptin receptor (LEPR) may contribute to a common form of obesity and, as a consequence, obesity-related diseases. We evaluated the potential role of genetic variation at the LEPR gene in heart sympathetic activity and other traits related to obesity in Mexican adolescents. Adolescents aged between 12 and 17 years, with steady body weight for the last three months were included," scientists in Mexico report.
"We evaluated anthropometric measurements, blood pressure, serum glucose, insulin, leptin levels, heart...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
Source: Pharma Law Weekly (2005-09-27)
More Articles from Pharma Law Weekly
- Apotex Corp.
Court rules in favor of Canadian drug maker in gabapentin ruling - Arriva Pharmaceuticals
Anti-inflammatory therapy developer names new general counsel - Biophan Technologies
Three new patents issued relating to MRI safety and visualization - ConjuChem
New drug platform retains therapeutic activity of original peptides - Cutting Edge Information
Authorized generics' branded pharmaceuticals gain share of generics market - Danish Medicines Agency
Requirements are stringent for authorization of epilepsy drug substitution - More from this issue of Pharma Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
